
Bristol's Astral Systems secures €26 million Series A to support medical isotope commercialisation - EU-Startups
Astral Systems is a British DeepTech firm that specializes in pioneering multi-state fusion technology. The company aims to produce critical medical isotopes for diagnosis, treatment, and research, addressing the fragile supply chain and potential global shortages in this area.
Bristol's Astral Systems secures €26 million Series A to support medical isotope commercialisation EU-Startups

| Jun 23, 2026 | TRIMTECH Therapeutics | $44.1M | Seed | United Kingdom |
| Jun 22, 2026 | Isometric | $36.4M | — | United Kingdom |
| Jun 18, 2026 | NHS AI agent startup | $12K | — | United Kingdom |
| Jun 18, 2026 | Space Forge | $12K | Grant | United Kingdom |